Abstract:BACKGROUND&OBJECTIVES: Human telomerase reverse transcriptase (hTERT) and telomerase-associated protein 1 (hTP1) are the important components of human telomerase. It has been shown that there is abnormal telomerase reactivation in human glioma cells. However, it is still unclear whether expressions of hTERT and hTP1 genes are also relevantly up-regulated with the reactivation. This study was undertaken to investigate the relationship among variations of expressions of hTERT and hTP1 genes, proliferation, and apoptosis of the glioma cells as well as effect of these variations on the development and progression of the gliomas. METHODS: The expressions of hTERT mRNA and protein, hTP1 mRNA and protein, and proliferating cell nuclear antigen (PCNA) as well as apoptosis in seventy human glioma specimenswith different malignant grades were studied using in situ hybridization, immunohistochemisry and in situ cell death detection (TUNEL method). RESULTS: The expressions of hTERT mRNA and protein were observed in 62 (88.6%) and 58 (82.9%) of 70 gliomas respectively. Their expression incidences did not appear to be significant difference among different malignant grade gliomas (P >0.05). All of these gliomas expressed hTP1 mRNA, hTP1 protein and PCNA (100%). The quantities of the above five kinds of positive cells were correlated positively with one another (r =0.589~0.882, P< 0.0005), and all of them were significantly fewer in WHO grade I~II gliomas than in grade III gliomas and the most in grade IV gliomas (P< 0.05~0.01). The apoptotic tumor cells were detected in all the specimens (100%). However, their quantity was more in WHO grade I~II gliomas than in grade III gliomas and the fewest in grade IV gliomas (P< 0.01), and was correlated negatively with the former five kinds of positive cells respectively (r =-0.551~ -0.775, P< 0.0005). CONCLUSION: These results suggest that all of the above parameters have the important referential value in the evaluation of biological behavior of gliomas. In glioma cells, abnormal expressions of hTERT and hTP1 genes are precondition of the telomerase reactivation, the latter plays possibly the important roles in the development and malignant progression of gliomas by inhibiting apoptosis of the tumor cells and promoting their proliferation.

Expression of Telomerase Activity and c-myc and Stimulatory Protein 1 in Human Ameloblastoma

Expression of pRb and E2F-1 and telomerase activity in ameloblastoma

Expression of telomerase and p53 in ameloblastoma]

Expression of Cyclin D1 and Its Inhibitors and Htert in Ameloblastoma

Expression of human telomerase RNA in ameloblastoma

Expression of telomerase and p 53 in ameloblastoma of the jaw

Expression of Telomerase Htrand Htert Gene in Human Amelobastoma

Expression and significance of hTERT, c-fos and c-jun in ameloblastoma

[Research on the Expression of C-Myc Mrna in Ameloblastoma].

Expression of P21~(waf1), P27~(kip1) and Cyclin E in Ameloblastoma

Immortalization of ameloblastoma cells via reactivation of telomerase function: Phenotypic and molecular characteristics.

[Expression of HOXC13 in Ameloblastoma].

Expression and Significance of P63, Bcl-2, PCNA, Ki-67 and MCM2 in Ameloblastoma

[Characterization of Growth and Proliferation in a Telomerase-Immortalized Ameloblastoma Cell Line].

Clinicopathological study on 322 cases of ameloblastoma

Telomerase Catalytic Sub-Unit Expression and Its Relation with That of C-Myc Gene in Human NSCLC Tissues

Hypoxia‐induced HIF‐1α and ZEB1 are critical for the malignant transformation of ameloblastoma via TGF‐β‐dependent EMT

Expression of Amelogenin Gene in Ameloblastoma Tissues

Exploring protein profiles and hub genes in ameloblastoma

Study on the Effect of Telomerase Gene Expression on the Cell Proliferation and Apoptosis in Human Gliomas

Enrichment of SOX2-Positive Cells in BRAF V600E Mutated and Recurrent Ameloblastoma